Intranasal Oxytocin Reduces Anxiety in Male Autism Model Rats But Worsens Social Behavior

Intranasal oxytocin reduced anxiety in male rats from a prenatal valproic acid autism model but increased anxiety in females and surprisingly impaired social interactions in both sexes — highlighting sex-dependent and potentially counterproductive effects.

Harding, Shannon M et al.·Behavioural pharmacology·2021·PreliminaryPreclinical Animal Study
RPEP-05435Preclinical Animal StudyPreliminary2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Preclinical Animal Study
Evidence
Preliminary
Sample
N=Animal study (both sexes)
Participants
Long Evans rat pups prenatally exposed to valproic acid (autism model)

What This Study Found

Intranasal oxytocin was anxiolytic for VPA males but anxiogenic for VPA females. In both sexes, oxytocin impaired social interactions in the sociability test and failed to improve sociosexual deficits. Prenatal VPA produced sex-specific behavioral deficits.

Key Numbers

500 mg/kg VPA GD12; 0.8 IU/kg oxytocin intranasal; anxiolytic in males; anxiogenic in females; impaired sociability both sexes

How They Did This

Animal study. Prenatal valproic acid (500 mg/kg, gestational day 12) in Long Evans rats. Intranasal oxytocin (0.8 IU/kg) or saline 30-60 min before testing. Elevated plus maze (anxiety), sociability, partner preference, ultrasonic vocalizations, and scent marking assessed.

Why This Research Matters

Oxytocin is being given to autistic children off-label. This study raises important safety concerns: oxytocin may help anxiety but could paradoxically worsen social behavior, and effects differ dramatically between sexes.

The Bigger Picture

These mixed and sex-dependent results mirror the inconsistency of human oxytocin trials in ASD. They suggest oxytocin is not a simple "social hormone" fix for autism and that its effects on anxiety versus social behavior may be dissociable or even opposing.

What This Study Doesn't Tell Us

VPA rat model may not fully replicate human ASD. Single oxytocin dose and timing. Acute administration — chronic effects may differ. Intranasal delivery in rats is imprecise compared to human nasal sprays.

Questions This Raises

  • ?Does chronic rather than acute oxytocin administration produce different social behavior outcomes?
  • ?Should oxytocin clinical trials in ASD stratify by sex given these dramatic sex differences?
  • ?Could oxytocin be useful specifically for ASD-associated anxiety while other approaches address social deficits?

Trust & Context

Key Stat:
Social behavior worsened Oxytocin — proposed as a "social hormone" treatment for autism — paradoxically impaired social interactions in both male and female rats in an autism model
Evidence Grade:
Moderate evidence: well-designed animal study with multiple behavioral measures and both sexes, but VPA model has limitations and results are from acute dosing.
Study Age:
Published 2021. Oxytocin for ASD continues to show mixed results in human trials, consistent with these animal findings.
Original Title:
Prenatal exposure to valproic acid and treatment with intranasal oxytocin have sex-specific effects on behavior in Long Evans rats.
Published In:
Behavioural pharmacology, 32(7), 561-570 (2021)
Database ID:
RPEP-05435

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Should I give my autistic child oxytocin nasal spray?

This study and others suggest caution. While oxytocin may help with anxiety in some individuals (particularly males), it paradoxically worsened social interactions in this animal model. Effects also differed dramatically between sexes. Discuss with a specialist before trying oxytocin for ASD.

Why would oxytocin worsen social behavior?

Oxytocin's effects are more complex than "boosting sociability." It increases sensitivity to social cues, which in some contexts or individuals may cause social withdrawal or anxiety. The optimal dose, timing, and patient characteristics for beneficial effects are still being determined.

Read More on RethinkPeptides

Cite This Study

RPEP-05435·https://rethinkpeptides.com/research/RPEP-05435

APA

Harding, Shannon M; Masters, Ellen C; D'Agata, Christina M; Agudelo Rivera, Aura C; Smith, Emma C. (2021). Prenatal exposure to valproic acid and treatment with intranasal oxytocin have sex-specific effects on behavior in Long Evans rats.. Behavioural pharmacology, 32(7), 561-570. https://doi.org/10.1097/FBP.0000000000000650

MLA

Harding, Shannon M, et al. "Prenatal exposure to valproic acid and treatment with intranasal oxytocin have sex-specific effects on behavior in Long Evans rats.." Behavioural pharmacology, 2021. https://doi.org/10.1097/FBP.0000000000000650

RethinkPeptides

RethinkPeptides Research Database. "Prenatal exposure to valproic acid and treatment with intran..." RPEP-05435. Retrieved from https://rethinkpeptides.com/research/harding-2021-prenatal-exposure-to-valproic

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.